Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Timolol for TKI-induced Paronychia
NCT06643416Phase 3Recruiting
- Sponsor
- Queen Mary Hospital
- Start
- Oct 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of timolol maleate gel + placebo in paronychia, sponsored by Queen Mary Hospital. Started Oct 2024; status: recruiting.
02
Drugs
timolol maleate gel + placebo
03
Conditions
paronychia
Beyond the preview
Go deeper on NCT06643416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06643416.